Bharat Edition

Bharatstox

← All stocks

Sharda Cropchem Ltd.

NSE: SHARDACROP · Chemicals

Sector

Chemicals

Size band

Small cap

Market cap

8,826cr

P/E

17.4

ROE

12.3%

Dividend yield

0.9%

No price is shown on this page, live or delayed. It records what management said on the earnings call, and the company’s filings.

Measured against

Operating margin17.0%
peer 13.0%
Revenue growth9.0%
peer −5.2%
Sharda Cropchem Ltd.peer median

Peer set

Pesticides & Agrochemicals · largest 12 of 17 measured at Q1 FY27 · financials via Screener
CompanyOperating marginRevenue growth
UPL Ltd.13.0%10.5%
PI Industries Ltd.22.0%−10.4%
Sumitomo Chemical India Ltd.22.0%0.6%
BASF India Ltd.10.0%24.5%
Fine Organic Industries Ltd.25.0%18.0%
Sharda Cropchem Ltd.17.0%9.0%
Rallis India Ltd.18.0%6.8%
Dhanuka Agritech Ltd.12.0%−12.5%
NACL Industries Ltd.11.0%−14.5%
Bharat Rasayan Ltd.15.0%−10.3%
Insecticides (India) Ltd.11.0%−11.4%
India Pesticides Ltd.14.0%−8.4%

No guidance on record.

This section quotes what management told the market on the quarterly earnings call. We have not transcribed one for Sharda Cropchem Ltd..

No broadcast calls recorded.

We log calls made about a company on business television — Zee Business, CNBC Awaaz and NDTV Profit — as they are stated on air. Nothing is on record for Sharda Cropchem Ltd..

Filings

latest 25 of 169
  • Analysts/Institutional Investor Meet/Con. Call Updates1 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Intimation of Schedule of Analyst / Institutional Investor Meeting1 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Shareholders meeting14 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Shareholders meeting14 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Shareholders meeting14 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Copy of Newspaper Publication10 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates4 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates30 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Copy of Newspaper Publication30 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Press Release29 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Investor Presentation29 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Outcome of Board Meeting29 Jul 2026
    RoutineBoard MeetingFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates22 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Copy of Newspaper Publication15 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Shareholders meeting14 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Certificate under SEBI (Depositories and Participants) Regulations, 20183 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Copy of Newspaper Publication3 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Record Date2 Jul 2026
    Medium impactDividendFiling PDF ↗
  • Shareholders meeting2 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Trading Window26 Jun 2026
    Medium impactInsider TradingFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates19 May 2026
    RoutineGeneralFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates18 May 2026
    RoutineGeneralFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates14 May 2026
    RoutineGeneralFiling PDF ↗
  • Dividend14 May 2026
    RoutineBoard MeetingFiling PDF ↗
  • Copy of Newspaper Publication14 May 2026
    RoutineGeneralFiling PDF ↗

The 25 most recent of 169 filings we hold for SHARDACROP, back to January 2024. Every filing, by day.

Disclaimer

Guidance is quoted from management commentary on quarterly earnings calls; the words are the company's own and the targets are theirs, not ours. Peer comparisons use quarterly financials sourced from Screener, with every company measured at the same fiscal quarter; the peer set is companies sharing the same industry classification, and comparisons are descriptive, not a ranking or a view. Filings are reproduced as companies filed them to the NSE and BSE; Bharatstox does not verify, endorse or comment on their contents. This page is for informational and educational purposes only and does not constitute investment advice, research, or a recommendation to buy or sell any security. Investing in securities markets is subject to market risks. Read all related documents carefully before investing.

Bharat ke stocks, har subah.

One daily brief on what India's SEBI-registered research analysts are calling. No noise, no spam, unsubscribe whenever.